A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

NCT01520727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 9-1067
DRUG: Placebo

Sponsor

Bial - Portela C S.A.